Cart
sales@molnova.com
Cyclosporin A-Derivative 2
CAS No. 156047-45-9
Cyclosporin A-Derivative 2( —— )
Catalog No. M30086 CAS No. 156047-45-9
Derivative 2 is A novel Derivative of Cyclosporin A.Cyclosporin A is an immunosuppressant that binds to cyclophilin and inhibits calcineurin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 259 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCyclosporin A-Derivative 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionDerivative 2 is A novel Derivative of Cyclosporin A.Cyclosporin A is an immunosuppressant that binds to cyclophilin and inhibits calcineurin.
-
DescriptionDerivative 2 is A novel Derivative of Cyclosporin A.Cyclosporin A is an immunosuppressant that binds to cyclophilin and inhibits calcineurin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number156047-45-9
-
Formula Weight1149.51
-
Molecular FormulaC58H104N10O13
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Val-Leu-Ala-D-Ala-Leu-Leu-Val-{Aaa}-{Abu}-{Sar}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Peel M, et al. Cyclophilin inhibitors as antiviral agents. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4485-92.
molnova catalog
related products
-
RO5166017
RO5166017 is an orally active, potent and selective trace amine-associated receptor 1 (TAAR1) agonist for the study of conditioned taste aversion frontal nerve disorders.
-
Guaiacol
Guaiacol is a precursor to various flavorants, such as eugenol and vanillin. Its derivatives are used medicinally as an expectorant, antiseptic, and local anesthetic.
-
TG-2-IN-1
TG-2-IN-1 is a potent transglutaminase-2 (TGM-2) inhibitor.TG-2-IN-1 is used in the study of cancer, neurological disorders, and immune system disorders.
